Canlyniadau Chwilio - Rob E. Aarnoutse

Mireinio'r Canlyniadau
  1. 1
    Implications of the global increase of diabetes for tuberculosis control and patient care

    Implications of the global increase of diabetes for tuberculosis control and patient care gan Rovina Ruslami, Rob E. Aarnoutse, Bachti Alisjahbana, André van der Ven, Reinout van Crevel

    Cyhoeddwyd 2010
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    New Drugs against Tuberculosis: Problems, Progress, and Evaluation of Agents in Clinical Development

    New Drugs against Tuberculosis: Problems, Progress, and Evaluation of Agents in Clinical Development gan Jossy van den Boogaard, Gibson Kibiki, Elton R. Kisanga, Martin J. Boeree, Rob E. Aarnoutse

    Cyhoeddwyd 2008
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Electronic monitoring of treatment adherence and validation of alternative adherence measures in tuberculosis patients: a pilot study

    Electronic monitoring of treatment adherence and validation of alternative adherence measures in tuberculosis patients: a pilot study gan Jossy van den Boogaard, Ramsey A. Lyimo, Martin J. Boeree, Gibson Kibiki, Rob E. Aarnoutse

    Cyhoeddwyd 2011
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Evaluation of Antiretroviral Drug Measurements by an Interlaboratory Quality Control Program

    Evaluation of Antiretroviral Drug Measurements by an Interlaboratory Quality Control Program gan J. A. H. Droste, Rob E. Aarnoutse, Peter P. Koopmans, Yechiel A. Hekster, David M. Burger

    Cyhoeddwyd 2003
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Pharmacokinetics and Tolerability of a Higher Rifampin Dose versus the Standard Dose in Pulmonary Tuberculosis Patients

    Pharmacokinetics and Tolerability of a Higher Rifampin Dose versus the Standard Dose in Pulmonary Tuberculosis Patients gan Rovina Ruslami, Hanneke M. J. Nijland, Bachti Alisjahbana, Ida Parwati, Reinout van Crevel, Rob E. Aarnoutse

    Cyhoeddwyd 2007
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Cost Evaluation of Dried Blood Spot Home Sampling as Compared to Conventional Sampling for Therapeutic Drug Monitoring in Children

    Cost Evaluation of Dried Blood Spot Home Sampling as Compared to Conventional Sampling for Therapeutic Drug Monitoring in Children gan Lisa C. Martial, Rob E. Aarnoutse, Michiel F. Schreuder, Stefanie Henriet, Roger J. M. Brüggemann, Manuela Joore

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Pharmacokinetics of First-Line Tuberculosis Drugs in Tanzanian Patients

    Pharmacokinetics of First-Line Tuberculosis Drugs in Tanzanian Patients gan Alma Tostmann, Charles Mtabho, Hadija Semvua, Jossy van den Boogaard, Gibson Kibiki, Martin J. Boeree, Rob E. Aarnoutse

    Cyhoeddwyd 2013
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Antituberculosis drug‐induced hepatotoxicity: Concise up‐to‐date review

    Antituberculosis drug‐induced hepatotoxicity: Concise up‐to‐date review gan Alma Tostmann, Martin J. Boeree, Rob E. Aarnoutse, Wiel C.M. de Lange, André van der Ven, Richard Dekhuijzen

    Cyhoeddwyd 2007
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Intensified antibiotic treatment of tuberculosis meningitis

    Intensified antibiotic treatment of tuberculosis meningitis gan Fiona V Cresswell, Lindsey te Brake, Rachel Atherton, Rovina Ruslami, Kelly E. Dooley, Rob E. Aarnoutse, Reinout van Crevel

    Cyhoeddwyd 2018
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Isoniazid, Rifampin, and Pyrazinamide Plasma Concentrations in Relation to Treatment Response in Indonesian Pulmonary Tuberculosis Patients

    Isoniazid, Rifampin, and Pyrazinamide Plasma Concentrations in Relation to Treatment Response in Indonesian Pulmonary Tuberculosis Patients gan Erlina Burhan, Carolien Ruesen, Rovina Ruslami, Arum Ginanjar, Hadiarto Mangunnegoro, Purwantyastuti Ascobat, Rogier Donders, Reinout van Crevel, Rob E. Aarnoutse

    Cyhoeddwyd 2013
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Rifampicin Reduces Plasma Concentrations of Moxifloxacin in Patients with Tuberculosis

    Rifampicin Reduces Plasma Concentrations of Moxifloxacin in Patients with Tuberculosis gan Hanneke M. J. Nijland, Rovina Ruslami, A. J. Suroto, David M. Burger, Bachti Alisjahbana, Reinout van Crevel, Rob E. Aarnoutse

    Cyhoeddwyd 2007
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    A Population Pharmacokinetic Model Incorporating Saturable Pharmacokinetics and Autoinduction for High Rifampicin Doses

    A Population Pharmacokinetic Model Incorporating Saturable Pharmacokinetics and Autoinduction for High Rifampicin Doses gan Robin J. Svensson, Rob E. Aarnoutse, Andreas H. Diacon, Rodney Dawson, Stephen H. Gillespie, Martin J. Boeree, Ulrika S. H. Simonsson

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Pharmacokinetics of Antituberculosis Drugs in Pulmonary Tuberculosis Patients with Type 2 Diabetes

    Pharmacokinetics of Antituberculosis Drugs in Pulmonary Tuberculosis Patients with Type 2 Diabetes gan Rovina Ruslami, Hanneke M. J. Nijland, I. Gusti N. Adhiarta, S.H.K.S. Kariadi, Bachti Alisjahbana, Rob E. Aarnoutse, Reinout van Crevel

    Cyhoeddwyd 2009
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Pharmacogenetics and Pharmacokinetics of Moxifloxacin in MDR-TB Patients in Indonesia: Analysis for ABCB1 and SLCO1B1

    Pharmacogenetics and Pharmacokinetics of Moxifloxacin in MDR-TB Patients in Indonesia: Analysis for ABCB1 and SLCO1B1 gan Nurul Annisa, Nadiya Nurul Afifah, Prayudi Santoso, Vycke Yunivita, Lindsey H. M. te Brake, Rob E. Aarnoutse, Melisa Intan Barliana, Rovina Ruslami

    Cyhoeddwyd 2025
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Pharmacokinetics of Moxifloxacin in Cerebrospinal Fluid and Plasma in Patients with Tuberculous Meningitis

    Pharmacokinetics of Moxifloxacin in Cerebrospinal Fluid and Plasma in Patients with Tuberculous Meningitis gan Jan‐Willem C. Alffenaar, Richard van Altena, H. J. Bökkerink, Gert Jan Luijckx, Dick van Soolingen, Rob E. Aarnoutse, Tjip S. van der Werf

    Cyhoeddwyd 2009
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Model-Based Meta-analysis of Rifampicin Exposure and Mortality in Indonesian Tuberculous Meningitis Trials

    Model-Based Meta-analysis of Rifampicin Exposure and Mortality in Indonesian Tuberculous Meningitis Trials gan Elin M. Svensson, Sofiati Dian, Lindsey te Brake, Ahmad Rizal Ganiem, Vycke Yunivita, Arjan van Laarhoven, Reinout van Crevel, Rovina Ruslami, Rob E. Aarnoutse

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Engaging community pharmacy in tuberculosis case detection (ENHANCE): a study protocol for an implementation study in Indonesia

    Engaging community pharmacy in tuberculosis case detection (ENHANCE): a study protocol for an implementation study in Indonesia gan Ivan Surya Pradipta, Carla Florencia, Cut Ainul Mardhiyyah, Firda Shafira Nurfadila, Kevin Aprilio, Rizky Abdulah, Bony Wiem Lestari, Rovina Ruslami, Trisasi Lestari, Rob E. Aarnoutse

    Cyhoeddwyd 2025
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Greater Early Bactericidal Activity at Higher Rifampicin Doses Revealed by Modeling and Clinical Trial Simulations

    Greater Early Bactericidal Activity at Higher Rifampicin Doses Revealed by Modeling and Clinical Trial Simulations gan Robin J. Svensson, Elin M. Svensson, Rob E. Aarnoutse, Andreas H. Diacon, Rodney Dawson, Stephen H. Gillespie, Vineshree Mischka Moodley, Martin J. Boeree, Ulrika S. H. Simonsson

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP

    Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP gan Vincent J. Lempers, Jeroen J. M. W. van den Heuvel, Frans G. M. Rüssel, Rob E. Aarnoutse, David M. Burger, Roger J. M. Brüggemann, Jan J. Koenderink

    Cyhoeddwyd 2016
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    Evaluation of moxifloxacin for the treatment of tuberculosis: 3 years of experience

    Evaluation of moxifloxacin for the treatment of tuberculosis: 3 years of experience gan Arianna D. Pranger, Richard van Altena, Rob E. Aarnoutse, Dick van Soolingen, D. R. A. Uges, Jos G.W. Kosterink, Tjip S. van der Werf, Jan‐Willem C. Alffenaar

    Cyhoeddwyd 2011
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: